Rhythm Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Rhythm Pharmaceuticals has a total shareholder equity of $152.7M and total debt of $109.2M, which brings its debt-to-equity ratio to 71.5%. Its total assets and total liabilities are $363.6M and $210.9M respectively.
Key information
71.5%
Debt to equity ratio
US$109.24m
Debt
| Interest coverage ratio | n/a |
| Cash | US$298.39m |
| Equity | US$152.70m |
| Total liabilities | US$210.88m |
| Total assets | US$363.57m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1RV's short term assets ($340.3M) exceed its short term liabilities ($97.6M).
Long Term Liabilities: 1RV's short term assets ($340.3M) exceed its long term liabilities ($113.3M).
Debt to Equity History and Analysis
Debt Level: 1RV has more cash than its total debt.
Reducing Debt: 1RV's debt to equity ratio has increased from 0% to 71.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1RV has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 1RV has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.